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treatment did not influence osteoclast differentiation in primary-cul-
tured monocytes of mouse bone marrow. In coculture of monocytes
and MC3T3-E1 cells, however, D3G induced both osteoblast and
osteoclast differentiation.
Conclusions: This study demonstrated that D3G increased the
proliferation and differentiation of osteoblast cells and enhanced
bone formation. These results suggest that D3G may be a good can-
didate for the treatment of osteoporosis
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Objectives: Cathepsin K expressed by osteoclasts and synovial
fibroblasts degrades key components of bone and cartilage, such
as type I and type II collagen, osteonectin, and aggrecan. Inhibition
of cathepsin K protease activity may be beneficial for prevention of
bone erosion and cartilage degradation in rheumatoid arthritis
(RA). The CIA rat model is an established model for studying
the pathology and treatment of RA. We studied the effect of
ONO-KK1-300-01(ONO), a cathepsin K inhibitor, on arthritis and
bone mineral density (BMD) in rats with collagen-induced arthritis
(CIA).
Methods: Seven-month-old female Sprague - Dawley rats were
divided into five groups: rats without CIA (CNT), CIA rats that
underwent ovariectomy (OVX) and were treated with ONO
(CIA + OVX + ONO), CIA rats that underwent OVX and were treated
with vehicle (CIA + OVX + Veh), CIA rats that underwent sham sur-
gery and were treated with ONO (CIA + sham + ONO), and CIA rats
that underwent sham surgery and were treated with vehicle
(CIA + sham + Veh). ONO was orally administered at a dose of
15 mg/kg daily for 4 weeks, beginning initial sensitization until death
at 4 weeks. Every week until death, we evaluated the hind paw thick-
ness and arthritis score. Hind paw thickness was evaluated by meas-
uring the ankle width from the medial malleolus to the lateral
malleolus using a constant - tension caliper. Arthritis was evaluated
according to the degree of severity and the extent of erythema and
edema of the periarticular tissue, scored as 0e3 points. The arthritis
score was the sum of the scores for the digit, metacarpophalangeal,
and wrist joints in the forepaw and the ankle joint in the hind paw.
BMD was measured by bone densitometry at the distal metaphysis
and the diaphysis of the femur.
Results: ONO administration suppressed the hind paw thickness
and arthritis score and prevented decrease in BMD. The
CIA + OVX + Veh group had the highest arthritis score. The hind
paw thickness and arthritis score in the CIA + OVX + Veh group
was significantly different from than in the CIA + OVX + ONO
group.
Although the CIA + OVX + Veh group did not show significant
decrease in BMD compared with the CIA + sham + Veh group, the
CIA + sham + ONO group showed a significantly high score in
BMD compared with the CIA + sham + Veh group.Conclusion: Our findings indicate that, in an animal model of
arthritis, cathepsin K inhibitors can prevent bone loss and arthritis.0045
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Objectives: The TRAF6-TAK1 axis is a key component of the NF-kB
and MAPK signaling pathways in response to various stimuli. How-
ever, the stimulus-specific control mechanism of the TRAF6-TAK1
axis has remained elusive.
Method: To examine the role of RACK1 in vitro, we have tried to
test RACK1 gain-of function and loss-of function analyses in primary
bone marrow-derived monocytes/macrophages or RAW264.7 cells.
Furthermore, to test RACK1's knockdown in vivo, we have injected
RACK1 siRNA into mice calvaris.
Results and conclusions: RACK1 gain-of function and loss-of
function analyses indicated that RACK1 is necessary for osteoclast
differentiation through the promotion of p38 activation. RACK1 asso-
ciated with multiple components of the RANK-mediated p38 path-
way, including RANK, TRAF6, TAK1, and MKK6, thereby leading
to the activation of the MKK6-p38 pathway. Importantly, knockdown
studies of RACK1 and TAK1 demonstrated that RACK1 acted as a
bridge for the bonding of MKK6 to the TRAF6-TAK1 complex. Fur-
thermore, local administration of RACK1 siRNA into mice calvarias
was found to decrease the RANKL-induced bone loss by reducing the
numbers of osteoclasts. These findings suggest that RACK1 plays an
important role in RANKL-induced p38 activation by facilitating the
association of MKK6 with TAK1, and may provide a molecular target
for a new therapeutic strategy.0061
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Objective: To investigate the optimum timing and how long did it
cost to build the osteoporosis model in C57/BL6 mice by ovariectomy
(OVX).
Methods: 50 six-week-old female C57/BL6 mice were divided
into 10 groups (A-J). Group A and F underwent BMD measurement
by DEXA on cranium in eight-week-old and twelve-week-old,
respectively. The BMD analysis of group B-E was performed in 8
weeks, 10 weeks, 12 week and 14 weeks after the mice underwent
OVX in eight weeks old. The BMD analysis of group G-J was per-
formed in 6 weeks, 8 weeks, 10 week and 12 weeks after the mice
underwent OVX in twelve weeks old.
Results: The mean BMD on cranium of twelve-week-old
mice(0.131 ± 0.030g/cm2) was significantly higher than the BMD
of eight-week-old mice(0.113 ± 0.042 g/cm2) (p < 0.05). There
was no significant difference between group AeE. The mean BMD
on cranium of group F(0.131 ± 0.030 g/cm2) was significantly higher
than the BMD of group H(0.113 ± 0.014g/cm2) (p < 0.05). And the
BMD decreased smoothly from H-J (p > 0.05).
Conclusions: The optimum age to build up the osteoporosis
model in C57/BL6 mice is twelve weeks old, and we should wait
at least 8 weeks before the model is established.
